Could poop transplants save sepsis patients?
NCT ID NCT07670299
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether fecal microbiota transplantation (FMT) can help ICU patients with sepsis. Sepsis is a life-threatening infection that can cause organ failure. The trial will give 60 adults either standard care or standard care plus FMT through a tube into the gut for three days. The main goal is to see if FMT reduces deaths within 90 days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- fecal microbiota transplantation (FMT)
- What this could lead to
- If it works, this could point toward a new treatment to lower death rates in ICU sepsis patients by restoring gut health.
- What could go wrong
- This is a small, early-stage trial with only 60 patients at one hospital. The treatment may not work or could cause side effects like fever or gut issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we optimize antibiotic dosing for children with sepsis?
- Could a gut microbiome transplant ease axial spondyloarthritis?
- Could starting feeds sooner shield preterm babies from infection?
- AI may predict transfusion needs to shield ICU patients from organ failure
- A simple blood test trend may flag ICU patients at risk
- Can brain waves predict thinking problems after sepsis?